(PDF) Lymphocyte Count Above 300 X 106/Ml 90 Days Post

Lymphocyte Count Above 300 X 106/Ml 90 Days Post Transplant Predicts Better Overall Survival After Alemtuzumab for Unrelated Donor Stem Cell Transplant

Biology of Blood and Marrow Transplantation - Netherlands

doi 10.1016/j.bbmt.2012.11.217

Full Text

Open PDF

Abstract

Available in full text

Date

February 1, 2013

Authors

Publisher

Elsevier BV

Related search

Dendritic Cells Recovery After Umbilical Cord Blood Transplant Is Superior to Related Donor Transplant and Predicts Better Survival

Biology of Blood and Marrow Transplantation

Transplantation

Hematology

2016

English

Donor Lymphocyte Experience in Pediatric Allogeneic Hematopoietic Stem Cell Transplant Patients

Biology of Blood and Marrow Transplantation

Transplantation

Hematology

2018

English

Successful Second Unrelated Donor Hematopoietic Stem Cell Transplant in a Patient With Dyskeratosis Congenital After First Graft Rejection

Experimental and Clinical Transplantation

Transplantation

2017

English

Survival After T-Cell Replete Haploidentical Related Donor Hematopoietic Cell Transplantation (Haplo-Hct) Using Post-Transplant Cyclophosphamide (PT-CY) Compared With HLA-Matched Related Donor (MRD) Transplant for Lymphomas

Biology of Blood and Marrow Transplantation

Transplantation

Hematology

2016

English

Association of Second Allogeneic Hematopoietic Cell Transplant vs Donor Lymphocyte Infusion With Overall Survival in Patients With Acute Myeloid Leukemia Relapse

English

HLA-DPA1 Mismatch Is Associated With Decreased Overall Survival Following Unrelated Donor Hematopoietic Stem Cell Transplantation

Biology of Blood and Marrow Transplantation

Transplantation

Hematology

2012

English

Donor Derived T-Cell Large Granular Lymphocyte Leukemia After Cord Blood Transplant for Pediatric T-Cell Lymphoblastic Leukemia

Bone Marrow Transplantation

Transplantation

Hematology

2017

English

Donor Risk Index Predicts Graft Failure Reliably but Not Post-Transplant Infections

English

Non-Transplant Patients With Haematologic Malignancies Have Better Survival Outcome Than Recipients of Haematopoietic Stem Cell Transplant (Hsct) After Admission to Intensive Care Unit (Icu)

Intensive Care Medicine Experimental

Critical Care

Intensive Care Medicine

2015

English

Amanote Research

Lymphocyte Count Above 300 X 106/Ml 90 Days Post Transplant Predicts Better Overall Survival After Alemtuzumab for Unrelated Donor Stem Cell Transplant

Biology of Blood and Marrow Transplantation - Netherlands

doi 10.1016/j.bbmt.2012.11.217

Full Text

Abstract

Categories

Date

Authors

Publisher

Related search

Dendritic Cells Recovery After Umbilical Cord Blood Transplant Is Superior to Related Donor Transplant and Predicts Better Survival

Donor Lymphocyte Experience in Pediatric Allogeneic Hematopoietic Stem Cell Transplant Patients

Successful Second Unrelated Donor Hematopoietic Stem Cell Transplant in a Patient With Dyskeratosis Congenital After First Graft Rejection

Survival After T-Cell Replete Haploidentical Related Donor Hematopoietic Cell Transplantation (Haplo-Hct) Using Post-Transplant Cyclophosphamide (PT-CY) Compared With HLA-Matched Related Donor (MRD) Transplant for Lymphomas

Association of Second Allogeneic Hematopoietic Cell Transplant vs Donor Lymphocyte Infusion With Overall Survival in Patients With Acute Myeloid Leukemia Relapse

HLA-DPA1 Mismatch Is Associated With Decreased Overall Survival Following Unrelated Donor Hematopoietic Stem Cell Transplantation

Donor Derived T-Cell Large Granular Lymphocyte Leukemia After Cord Blood Transplant for Pediatric T-Cell Lymphoblastic Leukemia

Donor Risk Index Predicts Graft Failure Reliably but Not Post-Transplant Infections

Non-Transplant Patients With Haematologic Malignancies Have Better Survival Outcome Than Recipients of Haematopoietic Stem Cell Transplant (Hsct) After Admission to Intensive Care Unit (Icu)